Mirati Therapeutics, Inc.
Profile
Mailing Address: 9393 Towne Centre Drive, Suite 200
San Diego, California
92121
Head Office Address: 9393 Towne Centre Drive, Suite 200
San Diego, California
92121
Contact Name: Jamie A. Donadio, Senior Vice President & CFO Principal Regulator: Quebec
Business e-mail address: donadioj@mirati.com Short Form Prospectus Issuer: No
Telephone Number: 858 332-3410 Reporting Jurisdictions: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland
Fax Number: Stock Exchange: NASDAQ
Date of Formation: May 8 2013 Stock Symbol: MRTX
Jurisdiction Where Formed: Delaware Auditor: Ernst & Young LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 60468T Transfer Agent: Computershare Investor Services Inc.
Financial Year-End: Dec 31 Size of Issuer (Assets): $25,000,001 to $100,000,000


View This Company's Documents